Oesophagus Barrettiensis

Oesophagus Barrettiensis (ICD-10: K22.7) est metaplasia epithelii oesophagi et conditio praemaligna, quae ex oesophagite propter refluctionem orta est^[1] et simul transformatio reversibilis cellularum videtur, quamquam in parte in adenocarcinomam transeat. Diagnosis et therapiae endoscopium adhibetur^[2].

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Symptomata et signa

Vicissitudo qualitatum cellularum de normalis ad praemalignas, oeseophagum Barrettiensem indicans, aliqua symptomata specificata non concitent, quamquam quibusdam cum sequentibus suspicio excitetur:

Pyrosis frequens ac manens
Dysphagia — difficultas devorandi
Haematemesis — sanguinem vomitans
Dolor sub sternum (quo oesophagus stomachum tangunt)
Odynophagia — edere dolorem efficiens, igitur pondus amittens involuntaria

At similius oesophagum Barrettiensem capi cum obesitate abdominali (vs. obesitate peripherico)^[3]. Machinatio autem eius exacta dubia est.

Nexus interni

Notae

↑ Shaheen NJ, Richter JE (2009). "Barrett's oesophagus". Lancet 373 (9666): 850-61
↑ Mansour NM, El-Serag HB, Anandasabapathy S (2017). "Barrett's esophagus: best practices for treatment and post-treatment surveillance". Ann Cardiothorac Surg 6 (2): 75-87
↑ Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007). "Central adiposity and risk of Barrett esophagus". Gastroenterology 133 (2): 403–11

Nexus externi

LGA de oesophago Barrettiensi. (Anglice)

[1] Shaheen NJ, Richter JE (2009). "Barrett's oesophagus". Lancet 373 (9666): 850-61

[2] Mansour NM, El-Serag HB, Anandasabapathy S (2017). "Barrett's esophagus: best practices for treatment and post-treatment surveillance". Ann Cardiothorac Surg 6 (2): 75-87

[3] Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL (2007). "Central adiposity and risk of Barrett esophagus". Gastroenterology 133 (2): 403–11

[1]

[2]

[3]